These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36613675)

  • 1. Urine-Derived Epithelial Cells as a New Model to Study Renal Metabolic Phenotypes of Patients with Glycogen Storage Disease 1a.
    Lenzini L; Iori E; Scannapieco F; Carraro G; Avogaro A; Vitturi N
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on glycogen storage disease type 1a animal models: a brief perspective.
    Petrova IO; Smirnikhina SA
    Transgenic Res; 2022 Dec; 31(6):593-606. PubMed ID: 36006546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine-Derived Renal Epithelial Cells (URECs) from Transplanted Kidneys as a Promising Immunomodulatory Cell Population.
    Pizzuti V; Donadei C; Balducelli E; Conte D; Gessaroli E; Paris F; Bini C; Demetri M; Di Nunzio M; Corradetti V; Alviano F; La Manna G; Comai G
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic characterisation of plasma in juveniles with glycogen storage disease type 1a (GSD1a) by high-resolution (1)H NMR spectroscopy.
    Duarte IF; Goodfellow BJ; Barros A; Jones JG; Barosa C; Diogo L; Garcia P; Gil AM
    NMR Biomed; 2007 Jun; 20(4):401-12. PubMed ID: 17149801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycogen storage disease type 1a patient with type 2 diabetes.
    Sun Y; Qiang W; Wu R; Yin T; Yuan J; Yuan J; Gu Y
    BMC Med Genomics; 2022 Sep; 15(1):205. PubMed ID: 36167523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a.
    Roseman DS; Khan T; Rajas F; Jun LS; Asrani KH; Isaacs C; Farelli JD; Subramanian RR
    Mol Ther; 2018 Mar; 26(3):814-821. PubMed ID: 29428299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
    Clar J; Mutel E; Gri B; Creneguy A; Stefanutti A; Gaillard S; Ferry N; Beuf O; Mithieux G; Nguyen TH; Rajas F
    Hum Mol Genet; 2015 Apr; 24(8):2287-96. PubMed ID: 25561689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a human induced pluripotent stem cell line, BRCi009-A, derived from a patient with glycogen storage disease type 1a.
    Katagami Y; Kondo T; Suga M; Yada Y; Imamura K; Shibukawa R; Sagara Y; Okanishi Y; Tsukita K; Hirayama K; Era T; Inoue H
    Stem Cell Res; 2020 Dec; 49():102095. PubMed ID: 33291009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a.
    Resaz R; Cangelosi D; Morini M; Segalerba D; Mastracci L; Grillo F; Bosco MC; Bottino C; Colombo I; Eva A
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32620541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary URECs: a source to better understand the pathology of renal tubular epithelia in pediatric hereditary cystic kidney diseases.
    Ziegler WH; Lüdiger S; Hassan F; Georgiadis ME; Swolana K; Khera A; Mertens A; Franke D; Wohlgemuth K; Dahmer-Heath M; König J; Dafinger C; Liebau MC; Cetiner M; Bergmann C; Soetje B; Haffner D
    Orphanet J Rare Dis; 2022 Mar; 17(1):122. PubMed ID: 35264234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors.
    Nakamura T; Ozawa T; Kawasaki T; Nakamura H; Sugimura H
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1402-8. PubMed ID: 11851840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease.
    Cao J; Choi M; Guadagnin E; Soty M; Silva M; Verzieux V; Weisser E; Markel A; Zhuo J; Liang S; Yin L; Frassetto A; Graham AR; Burke K; Ketova T; Mihai C; Zalinger Z; Levy B; Besin G; Wolfrom M; Tran B; Tunkey C; Owen E; Sarkis J; Dousis A; Presnyak V; Pepin C; Zheng W; Ci L; Hard M; Miracco E; Rice L; Nguyen V; Zimmer M; Rajarajacholan U; Finn PF; Mithieux G; Rajas F; Martini PGV; Giangrande PH
    Nat Commun; 2021 May; 12(1):3090. PubMed ID: 34035281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: Hepatocellular carcinoma in type 1a glycogen storage disease with identification of a glucose-6-phosphatase gene mutation in one family.
    Nakamura T; Ozawa T; Kawasaki T; Yasumi K; Wang DY; Kitagawa M; Takehira Y; Tamakoshi K; Yamada M; Kida H; Sugie H; Nakamura H; Sugimura H
    J Gastroenterol Hepatol; 1999 Jun; 14(6):553-8. PubMed ID: 10385064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular, Biochemical, and Clinical Characterization of Thirteen Patients with Glycogen Storage Disease 1a in Malaysia.
    Abdul Wahab SA; Yakob Y; Mohd Khalid MKN; Ali N; Leong HY; Ngu LH
    Genet Res (Camb); 2022; 2022():5870092. PubMed ID: 36160031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen storage disease type 1a in three siblings with the G270V mutation.
    Parvari R; Isam J; Moses SW
    J Inherit Metab Dis; 1999 Apr; 22(2):149-54. PubMed ID: 10234610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Glycogen Storage Disease Type 1a Mimicking Familial Chylomicronemia Syndrome.
    Olgac A; Okur I; Biberoğlu G; Ezgü FS; Tümer L
    Balkan J Med Genet; 2021 Jun; 24(1):103-106. PubMed ID: 34447667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.
    Melis D; Pivonello R; Parenti G; Della Casa R; Salerno M; Balivo F; Piccolo P; Di Somma C; Colao A; Andria G
    J Pediatr; 2010 Apr; 156(4):663-70.e1. PubMed ID: 20022338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sex hormone-binding globulin levels are reduced and inversely associated with intrahepatic lipid content and saturated fatty acid fraction in adult patients with glycogen storage disease type 1a.
    Simons PIHG; Valkenburg O; Telgenkamp I; van der Waaij KM; de Groot DM; Veeraiah P; Bons JAP; Derks TGJ; Schalkwijk CG; Schrauwen-Hinderling VB; Stehouwer CDA; Brouwers MCGJ
    J Endocrinol Invest; 2022 Jun; 45(6):1227-1234. PubMed ID: 35132570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
    Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
    J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical trapping in glycogen storage disease 1a.
    Wittenstein B; Klein M; Finckh B; Ullrich K; Kohlschütter A
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S70-4. PubMed ID: 12373576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.